D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.
4d
News-Medical.Net on MSNTransforming genetic deafness treatment with base editingCongenital hearing loss refers to impaired auditory function that occurs due to genetic causes. GJB2 is the gene responsible ...
When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...
The Louisville Bats unveiled a new secondary logo that honors the team's 25th season playing at Louisville Slugger Field. The new logo features subtle references to Louisville and Kentucky.
Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...
Apple has donated 30 million yuan ($4.1 million) to Zhejiang University to help fund app development training in China. CEO Tim Cook has also visited Hangzhou, China’s artificial intelligence ...
Discovery coincides with the announcement of the Administration's Executive Order: 'Immediate Measures to Increase American Mineral ...
Progressive Web Apps, or PWAs, can turn app-like websites into website-like apps. Browsers are beefing up support for these ...
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time gene therapy for the treatment of patients with vision loss due to a ...
Data from those with statutory health insurance will soon be accessible for research. The BfArM is developing the necessary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results